Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
11/1998
11/11/1998EP0876497A1 Production of recombinant baculoviruses
11/10/1998US5834302 Method for producing RNA viruses from CDNA
11/10/1998US5834256 Novel retroviral packaging system, transfection in human cells
11/10/1998US5833980 Inoculating poultry, live virus vaccine
11/10/1998US5833975 Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
11/10/1998CA2045649C Attenuated enteroviruses and rhinoviruses
11/05/1998WO1998049334A1 Novel internal ribosome entry site and vector containing same
11/05/1998WO1998049333A2 Eukaryotic gene expression cassette and uses thereof
11/05/1998WO1998048834A1 Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents
11/05/1998DE19712541C1 Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen Papillomaviruses means for their detection as well as for the treatment of diseases caused by them
11/05/1998CA2258490A1 Novel internal ribosome entry site and vector containing same
11/04/1998EP0874910A1 Peptide-enhanced cationic lipid transfections
11/04/1998EP0874904A1 Methods for delivering dna to muscle cells using recombinant adenoassociated virus virions
11/03/1998US5831016 Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
11/03/1998US5830852 Compositions for insulin-receptor mediated nucleic acid delivery
11/03/1998US5830759 Unique associated Kaposi's sarcoma virus sequences and uses thereof
11/03/1998US5830745 Genetic engineered herpes virus
11/03/1998US5830723 Method for immortalizing chicken cells
11/03/1998US5830688 DNA sequences, vectors, recombinant viruses and method which employs recombinant vaccinia viruses capable of muliplying in CHO cells
11/03/1998US5830641 Nucleotide sequence used as hybrid probe
11/03/1998US5830638 Cell line and processes for the replicating rabies viruses and detecting them quantitatively
11/03/1998US5830477 Vaccine against rabies and process for preparation thereof
11/03/1998US5830458 Method for destroying a diseased human cell
10/1998
10/29/1998WO1998047521A1 Phages, methods for growing and detecting them and their use
10/29/1998WO1998039426A3 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products
10/29/1998CA2797661A1 Targeted gene modification by parvoviral vectors
10/28/1998EP0873401A1 Novel retrovirus and diagnostic methods
10/28/1998EP0873138A2 Improved pharmaceutical compositions
10/28/1998CN1196956A Influenza vaccine
10/27/1998US5827750 Human virus associated with chronic fatigue immune deficiency syndrome and assay therefore
10/27/1998US5827738 Sustainable chick cell line infected with Marek's disease virus
10/27/1998US5827702 Contacting an ocular cell with exogenous nucleic acid under conditions permissive for it uptake and expression; genetic engineering
10/27/1998US5827696 Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system
10/27/1998US5827647 Treating samples with isolated empty parvovirus capsids, then detecting antigen-antibody complexes for diagnosis, also kits
10/27/1998US5827516 Decreasing major histocompatibility complex class ii antigen in mammal by introducing into antigen presenting cell an expression vector comprising a nucleic acid molecule coding for expression of peptide which binds to mhc class ii molecule
10/22/1998WO1998046778A1 Transgenomic viruses and the use thereof
10/22/1998WO1998046769A1 Composition and method for inducing an immune response against tumour-related antigens
10/22/1998WO1998046728A1 Methods for increasing the efficiency of recombinant aav product
10/22/1998WO1998046073A1 Improved storage and maintenance of blood products
10/22/1998CA2286721A1 Improved storage and maintenance of blood products
10/22/1998CA2286477A1 Composition and method for inducing an immune response against tumour-related antigens
10/21/1998EP0872553A1 Chimeric and/or growth-restricted flaviviruses
10/21/1998EP0872249A1 Gene transfer preparation
10/21/1998EP0871754A1 Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant
10/21/1998EP0871753A2 Method for obtaining retroviral vector supernatant having high transduction efficiency
10/21/1998EP0871742A2 Vectors and viruses for use in gene therapy
10/21/1998EP0871483A1 Helper virus-free aav production
10/21/1998EP0871482A1 Recombinant vesiculoviruses and their uses
10/21/1998EP0871459A1 Vector and method of use for nucleic acid delivery to non-dividing cells
10/21/1998EP0871363A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
10/21/1998EP0738327B1 Host-vector system for use in gene therapy
10/21/1998EP0586438B1 Hepatitis a virus production
10/21/1998CN1196390A Chicken Marek's disease virus genic mutant strain and its application
10/20/1998US5824777 Isolated amino acid sequences of the complete cdna sequence coded by the rna genome of the aik-c strain
10/20/1998US5824536 Influenza virus replicated in mammalian cell culture and vaccine production
10/20/1998US5824535 Diagnosing infections in shrimp; treating sample with protease inhibitors; genetic engineering
10/20/1998US5824482 Detection of antibodies for lav virus and antigens doe diagnosis with peptides
10/20/1998US5824468 Detection of listeria by means of recombinant bacteriophages
10/20/1998US5824466 Can be used for in vitro detection of skin disorders, cancers
10/20/1998US5824316 Deleting the nucleic acid sequence encoding the leader (l) proteinase from an infectious cdna copy of the viral genome
10/15/1998WO1998045415A1 Method for inactivating a virus
10/15/1998WO1998045323A1 Synthetic peptides useful in biological assays for detecting infections caused by group o hiv-1 viruses
10/15/1998WO1998044946A1 Viral obesity methods and compositions
10/15/1998WO1998044945A1 Non-infectious, protease defective hiv particles and nucleic acid molecules encoding therefor
10/15/1998WO1998044944A2 Stabilized human papillomavirus formulations
10/15/1998WO1998044938A1 Modified proteins which bind extracellular matrix components
10/15/1998WO1998044788A2 Animal model for evaluation of vaccines
10/15/1998WO1998024887A3 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof
10/15/1998WO1998022588A3 An improved method for the production and purification of adenoviral vectors
10/15/1998CA2286690A1 Method for inactivating a virus
10/15/1998CA2286294A1 Stabilized human papillomavirus formulations
10/14/1998EP0870508A1 Influenza vaccine
10/14/1998EP0870058A1 Molecular sequence of swine retrovirus and methods of use
10/14/1998EP0870050A2 Toxic-protein expressing viruses and producer cell lines
10/14/1998EP0870049A2 Complementary adenoviral vector systems and cell lines
10/14/1998EP0870044A1 Regulated protein expression in stably transfected mammalian cells
10/14/1998EP0870013A1 Systems and methods for removing viral agents from blood
10/13/1998US5821124 Hybridoma cell lines and antibodies that bind noggin
10/13/1998US5821070 Antibodies reactive with retinoblastoma binding proteins and methods of using same
10/13/1998US5820871 Influenza virus, due to its genetic variability, stimulates immunity without developing a tolerance
10/13/1998US5820869 Gene comprising dna sequence encoding the envelope protein
10/13/1998US5820868 Recombinant protein production in bovine adenovirus expression vector system
10/13/1998US5820859 Administering a drug congugated to an antibody specific for the extracellular domain of gp180(erbb-3), which will not bind to erbb-2 or erbb; human mammary tumor line targeting
10/08/1998WO1998044143A1 Polymer-modified viruses
10/08/1998WO1998044132A1 VIRAL VECTORS HAVING CHIMERIC ENVELOPE PROTEINS CONTAINING THE IgG-BINDING DOMAIN OF PROTEIN A
10/08/1998WO1998044122A1 Method for producing non-infectious recombinant picornavirus particles
10/08/1998WO1998044121A1 Modified adenoviral fiber and target adenoviruses
10/08/1998WO1998044093A1 Novel dna vector and vaccines containing novel recombinant dna vectors as the active ingredient
10/08/1998WO1998043668A1 Attenuated respiratory syncytial virus
10/08/1998CA2285565A1 Modified adenoviral fiber and target adenoviruses
10/08/1998CA2285416A1 Polymer-modified viruses
10/07/1998EP0869184A2 Vaccin for immunisation against TBE viral infections and method or its preparation
10/07/1998EP0868522A1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them
10/06/1998US5817491 Enveloped vector particle; vesicular stomatitis virus
10/06/1998CA2072797C Use of tri (n-butyl) phosphate at low ph in solutions of biologically active proteins for enhanced virucidal activity
10/04/1998CA2234201A1 Rabies recombinant adenovirus
10/01/1998WO1998042856A1 Vectors and viral vectors, and packaging cell lines for propagating same
10/01/1998WO1998042847A2 Papilloma virus main capsid protein and the use thereof in diagnosis, therapy and vaccination
10/01/1998WO1998042830A2 Noey2 gene compositions and methods of use
10/01/1998WO1998042195A1 Replication-competent herpes simplex viruses
1 ... 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 ... 267